Princeton startup SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
Apply by Sept 8 for our next I-Corps short course Read more about Apply by Sept 8 for our next I-Corps short course
